Julia Tamulis focuses her practice on counseling a diverse range of clients on complex healthcare regulatory issues affecting operations and compliance matters. Julia provides healthcare regulatory guidance to health plans on Medicare Advantage and risk adjustment matters. She also advises pediatric hospital systems on compliance issues, including daily operations matters and internal compliance audits and reviews.
Drawing on her healthcare regulatory experience, Julia assists with internal compliance reviews and responding to government investigations, including defending companies facing government scrutiny in False Claims Act (FCA) matters. She has represented clients in the medical device, pharmaceutical, long-term care, and imaging sectors, as well as senior healthcare executives, before U.S. Attorneys’ Offices and the Department of Health and Human Services (HHS) Office of Inspector General in FCA, Stark Law, and Anti-Kickback Statute enforcement actions.
American Health Law Association (AHLA) — Hospitals and Health Systems Practice Group, Chair (2023-2025), Vice Chair (2018-2022), Leadership Development Program (2015-2016)
Women’s White Collar Defense Association
D.C. Bar Association — Health Law Section, Steering Committee Co-Chair (2016-2018); Health Law Section, Steering Committee (2015-2016); Health Law Section, New Practitioners Planning Committee (2014-2017)
Successfully defended a number of clients across industry sectors, including hospitals, physician practices, hospices, home health agencies and DMEPOS suppliers, in appealing audit results where statistical sampling was used to calculate to extrapolated overpayment demands.
Representation of a national healthcare company in an investigation related to allegations of fraudulent risk adjustment coding practices. Matter involved government disclosure and an analysis of data correction obligations.
Representation of a Medicare Advantage Organization in an investigation related to data-driven coding anomalies and practices detected at a large contracted provider group.
Representation of a Medicare Advantage Organization and its wholly-owned provider group in an internal investigation related to allegations of improper coding practices, hostile work environment, and non-compliance with Medicare requirements.
Representation of a Fortune 50 healthcare company in conducting oversight of network provider marketing practices and compliance with Medicare marketing regulations.
Representation of a Medicare Advantage plan in multiple internal investigations related to its grievance and appeal procedures.
Representation of a Fortune 50 healthcare company in its response to a third-party grand jury subpoena.
Developed and implemented compliance protocols, strategies, and data-driven analytics for a Medicare Advantage plan to conduct oversight of network providers’ risk adjustment practices and ensure plan-wide compliance with Medicare regulations.
Provided regulatory guidance to a Medicare Advantage plan regarding participation requirements for CMS innovative payment models, including Medicare Shared Savings Program (MSSP) accountable care organizations (ACOs), and Direct Contracting and Primary Care First models.
Conducted due diligence and regulatory analysis for a Medicare Advantage plan in connection with multiple transactions involving multispecialty physician practice groups, management service organizations (MSOs), and accountable care organizations. (ACOs)
Washington, D.C. Super Lawyers “Rising Star” (2016-2022)
The George Washington University Law School — J.B. and Maurice C. Shapiro Public Service Fellowship Recipient
American Intellectual Property Law Association (AIPLA) Quarterly Journal — Editorial Staff Member
University of Oxford — International Human Rights Law Program (2009)